Showing 1 - 10 of 124
Persistent link: https://www.econbiz.de/10009509405
Persistent link: https://www.econbiz.de/10009548834
Persistent link: https://www.econbiz.de/10009530131
Persistent link: https://www.econbiz.de/10010345596
Persistent link: https://www.econbiz.de/10010416365
"Substandard and counterfeit drugs represent a global public health crisis. However, there is little economic analysis of the market given the paucity of data. Focusing on 8 drug types on the WHO-approved medicine list, we constructed an original dataset of 899 drug samples from 17 low- and...
Persistent link: https://www.econbiz.de/10008933532
Persistent link: https://www.econbiz.de/10011408590
Focusing on 8 drug types on the WHO-approved medicine list, we constructed an original dataset of 899 drug samples from 17 low- and median-income countries and tested them for visual appearance, disintegration, and analyzed their ingredients by chromatography and spectrometry. Fifteen percent of...
Persistent link: https://www.econbiz.de/10013128895
This paper uses an audit sample and a consumer survey to study the intriguing market of online prescription drugs facing US customers, and assesses the role that certification agencies play in online drug markets. On the supply side, we acquire samples of five popular brand-name prescription...
Persistent link: https://www.econbiz.de/10013091236
Pharmaceutical products can be of poor quality either because they contain zero correct active ingredient (referred to as "counterfeit") or because they contain a non-zero but incorrect amount of the right active ingredient (referred to as "substandard"). While both types of poor-quality drugs...
Persistent link: https://www.econbiz.de/10013036913